For this year’s SynBioBeta conference, Data Collective founder and investor Matt Ocko hosted a panel on Abundance and Scarcity. Matt backs entrepreneurs attacking trillion-dollar problems to “amplify capitalism’s benefits and reduce its costs to society.” In Matt’s own words, his team is creating a future of “abundance, comity, and amity.” Matt invited artist and storyteller […]
When I speak with non-technical, non-biotech audiences, I’m always looking for a place where we can start the conversation. These days, it’s with brewing. Most people, remember, know little-to-nothing about the way biology is impacting their lives. Most people, I believe, want to know. So these days, I start the conversation with beer and wine. Both […]
“You’re into Devo?” he asked. “Aren’t you?” His tone mocking. As if there was something wrong with it. Because for him, Yeah. Devo was too mainstream. Fake alternative. He was above that, and what he thought they stood for. “Of course I am,” I answered, thinking, Whatanasshole. “How could you not be?” Because at the time […]
This week I’ve been thinking a lot about this MIT Technology Review article on writing the yeast genome. The article profiles NYU’s Jef Boeke, one of the founders and leaders of Genome Project write (GP-write). Writing a genome, which is still expensive, will drive advances across many fields (I’ve written about this project in the […]
Organism or microbe design is an emerging industry. It’s analogous to the semi-conductor industry. Companies design and manufacture the semi-conductors found in computers, phones, cars, and televisions. Today, end-users rarely make semi-conductors themselves. They hire the expertise and apply what is manufactured to create a product. Organism design companies are reprograming yeast and bacteria to produce […]
Netflix just started airing Altered Carbon. It’s a rad take Richard K. Morgan’s 2002 cyberpunk novel. One of my favorite genres, cyberpunk typically explores how the street repurposes tech, life in cyberspace and off-planet. Last fall, I reread William Gibson’s Sprawl Trilogy – Neuromancer, Count Zero, and Mona Lisa Overdrive. (Neuromancer, BTW, is credited with […]
Here’s a spoken word version of the keynote I gave at Biofabricate 2017. To learn more about why you need a bio strategy, click here.
Happy New Year! Over the holidays, I unsubscribed from dozens of newsletters. I was very critical in thinking through whether a newsletter belonged in my email box. Was it helping me stay informed? Was it inspiring? Or, was it wasting (virtual) space? Here are a few of the newsletters I subscribe to stay up to date on biotech, […]
Good Riddance 2017 It was a good year, but not without its challenges. The TL;DR is: mL grew more than 10 percent but is still down from its 2015 high. I co-authored and published What’s Your Bio Strategy? I moderated a panel at SynBioBeta SF17 and keynoted at Biofabricate 4 and enjoyed it. I now […]
I recently appeared on a podcast talking about messagingLAB, the work we do to translate science for specific audiences, my book What’s Your Bio Strategy?, and how life sciences companies are using the blockchain. Listen on Spreaker. Listen on iTunes.